EyePoint Pharmaceuticals Secures New Patient Access Agreement with Vizient Inc. for DEXYCU®

Ads

You May Also Like

Precision Therapeutics Reports First Quarter 2018 Financial Results

MINNEAPOLIS, May 15, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the ...